Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)-Reference-Cited by-同舟云学术

Biweekly administration of docetaxel and vinorelbine as second-line chemotherapy for patients with stage IIIB and IV non-small cell lung cancer: a phase II study of the Galician Lung Cancer Group (GGCP 013-02)

Published:2007-11 Issue:10 Volume:18 Page:1201-1206
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Vázquez Sergio,Huidobro Gerardo,Amenedo Margarita,Fírvida José Luis,León Luis,Lázaro Martín,Grande Carlos,Mel José Ramón,Ramos Manuel,Salgado Mercedes,Casal Joaquín

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference33 articles.

1. Lung cancer;Evans;Oncologist,2001

2. Platinums in lung cancer: sufficient or necessary?;Bunn;J Clin Oncol,2005

3. American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003;Pfister;J Clin Oncol,2004

4. Quality-of-life considerations in patients with advanced lung cancer: effect of topotecan on symptom palliation and quality of life;Gralla;Oncologist,2004

5. Randomized, multinational, phase III study of docetaxel plus platinum combinations versus vinorelbine plus cisplatin for advanced non-small-cell lung cancer: the TAX 326 Study Group;Fossella;J Clin Oncol,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Second and third line treatment in non-small cell lung cancer;Critical Reviews in Oncology/Hematology;2009-08

2. Biweekly docetaxel-containing chemotherapy may be the optimal schedule;Anti-Cancer Drugs;2008-04